With 1.1 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.85 million shares. The 52-week range on RGEN shows that it touched its highest point at $182.52 and its lowest point at $102.96 during that stretch. It currently has a 1-year price target of $184.00. Beta for the stock currently stands at 1.11.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of RGEN was up-trending over the past week, with a rise of 1.52%, but this was down by -12.09% over a month. Three-month performance dropped to -19.64% while six-month performance fell -17.06%. The stock lost -16.05% in the past year, while it has lost -13.58% so far this year. A look at the trailing 12-month EPS for RGEN yields -0.41 with Next year EPS estimates of 2.17. For the next quarter, that number is 0.39. This implies an EPS growth rate of 6.18% for this year and 29.16% for next year.
Float and Shares Shorts:
At present, 56.18 million RGEN shares are outstanding with a float of 53.12 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for RGEN since 9 analysts follow the stock currently. There are 7 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $1.57824 being high and $1.50831 being low. For RGEN, this leads to a yearly average estimate of $1.53828.
